Top Story

Getty Images 1593591042
Pulmonary
CDC surveillance report cites concern of harmful mold infections
Localized findings warrant public health concern of invasive mold disease among at-risk individuals.
Featured
Yassine Sassi (standing), associate professor at the Fralin Biomedical Research Institute at VTC, and Aymen Halouani, first author of the study.
Pulmonary
Protein restoration may reverse lung disease
N Tidal 1 a385011
COPD
Company seeks to expand use of AI-based COPD diagnostic tool
Latest News
CDC vaccine schedules
Sponsored
CDC vaccine schedules
July 21, 2026
Getty Images 2224332000
European scientists warn that severe asthma remains a major health burden despite advanced treatments
August 5, 2026
Getty Images 1446874328
Inhaled marijuana linked to increased risk of asthma attacks
August 5, 2026
Getty Images 863542630
Farm bacteria linked to lower childhood asthma risk
July 31, 2026
Getty Images 2224332000
Asthma
European scientists warn that severe asthma remains a major health burden despite advanced treatments
Asthma
Inhaled marijuana linked to increased risk of asthma attacks
Asthma
Farm bacteria linked to lower childhood asthma risk
Asthma
New gene variant linked to asthma risk via inflammatory lipid pathway
N Tidal 1 a385011
COPD
Company seeks to expand use of AI-based COPD diagnostic tool
COPD
Study to examine novel test for COPD exacerbations
COPD
Beta blockers show no additional risk after myocardial infarction in COPD patients
COPD
Light physical activity can help patients with COPD live longer
Getty Images 1593591042
Pulmonary
CDC surveillance report cites concern of harmful mold infections
Pulmonary
Protein restoration may reverse lung disease
Pulmonary
RNA-based testing can improve diagnostic accuracy, treatment selection in NSCLC patients
Pulmonary
TLR5 deficiency linked to IPF risk
Spotlight
Notable stories and studies
CDC vaccine schedules
Presented by Ascend Media
CDC vaccine schedules
Pulmonary drug market forecast
Presented by Ascend Media
Pulmonary drug market forecast
Advocate for better air
Presented by Ascend Media
Advocate for better air
More from Pulmonary
New gene variant linked to asthma risk via inflammatory lipid pathway
Researchers identify genetic and epigenetic mechanisms that may explain asthma susceptibility in Asian populations.
July 31, 2026
Getty Images 1173676757
Beta blockers show no additional risk after myocardial infarction in COPD patients
Research finds that beta-blocker use after a first-time MI was associated with a lower mortality in patients who have COPD with no increased risk.
July 29, 2026
Myocardial Infarction
Light physical activity can help patients with COPD live longer
Study finds that physical activity doesn’t have to be strenuous to make a difference.
July 29, 2026
Light Physical Activity
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
Advocate for better air
RNA-based testing can improve diagnostic accuracy, treatment selection in NSCLC patients
Real-world study demonstrates the diversity and complexity of genomic mutations causing MET exon 14 skipping.
July 28, 2026
Getty Images 2199475157
TLR5 deficiency linked to IPF risk
Identification of key receptor could lead to new therapeutic target to prevent or slow pulmonary fibrosis.
July 27, 2026
Getty Images 1455289630
How lung cancer can hijack the nervous system
Disrupting the tumor-to-brain connection can reduce the risk of developing cachexia and improve patient outcomes.
July 24, 2026
Getty Images 939771318
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
Novel peptide could eliminate harmful inflammation at its source
Findings could pave the way for treatments targeting asthma and other inflammatory diseases.
July 23, 2026
Getty Images 2231226744
Vitronectin opens door to novel PF therapies
Discovery of the protein’s critical role in lung scarring could improve healing for patients who have pulmonary fibrosis.
July 23, 2026
Gang Liu, PhD
Kinaset Therapeutics announces first patient dosing in phase 2b of severe asthma trial
Study evaluates frevecitinib (KN-002), an inhaled pan-JAK inhibitor, in patients receiving medium-to-high dose ICS/LABA therapy.
July 23, 2026
Getty Images 1445996148
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
Usage of COPD treatment options lower among Black population
Research highlights inequities in COPD care among minority groups.
July 21, 2026
Copd Black Population
Virtual reality could help ease anxiety and depression in COPD patients
In-depth analysis suggests the technology may serve as a valuable addition to pulmonary rehabilitation.
July 21, 2026
Vr Anxiety
Silicosis breakthrough: Epithelial cells are key activators
Scientists disprove previous assumptions that the incurable lung disease is initiated by immune cells.
July 16, 2026
Michelle Tate, PhD, and Maggie Lam, PhD
Most Popular
Farm bacteria linked to lower childhood asthma risk
How lung cancer can hijack the nervous system
Novel peptide could eliminate harmful inflammation at its source
TLR5 deficiency linked to IPF risk
RNA-based testing can improve diagnostic accuracy, treatment selection in NSCLC patients
Beta blockers show no additional risk after myocardial infarction in COPD patients